The Effects of Sitagliptin on Type 2 Diabetic Patients
Phase 4
Recruiting
- Conditions
- Type 2 diabetes mellitus.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20191209045671N1
- Lead Sponsor
- Abidi pharmacy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with type 2 diabetes mellitus
Healthy physical conditions
No history of taking DPP-4 inhibitors
Not being pregnant for women
informed consent to participate in the study
Exclusion Criteria
A history of malignancy or diseases such as AIDS or hepatitis
A history of acute psychological diseases
Severe renal dysfunction
cardiovascular disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decreased fasting blood glucose. Timepoint: Before and after the intervention. Method of measurement: Biochemical-laboratory method.;Improvement of plasma lipid profiles. Timepoint: Before and after the intervention. Method of measurement: Biochemical-laboratory method.;Improvement of cognitive functions. Timepoint: Before and after the intervention. Method of measurement: wechsler tool.;Improvement in renal function. Timepoint: Before and after the intervention. Method of measurement: Biochemical-laboratory method.;Improve in pancreatic efficiency. Timepoint: Before and after the intervention. Method of measurement: Biochemical-laboratory method.
- Secondary Outcome Measures
Name Time Method